Data from the phase 3 BART trial (NCT02951325) show that adjuvant radiotherapy after radical cystectomy and chemotherapy improved locoregional failure-free survival (LRFS) and disease-free survival (DFS) without increasing severe late toxicity in…
Data from the phase 3 BART trial (NCT02951325) show that adjuvant radiotherapy after radical cystectomy and chemotherapy improved locoregional failure-free survival (LRFS) and disease-free survival (DFS) without increasing severe late toxicity in…